Story · Medicine & Biotech

Juan Osorio: Can We Harness CD40 Agonism to Treat Bladder Cancer?

1 outlet · first reported by OncoDaily on

Juan Osorio, Assistant Attending at Memorial Sloan Kettering Cancer Center and Director of Clinical Operations and Translational Immunology at The Rockefeller University, shared on LinkedIn: “Excited to share our new (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study
    Juan Osorio: Can We Harness CD40 Agonism to Treat Bladder Cancer?

    Juan Osorio, Assistant Attending at Memorial Sloan Kettering Cancer Center and Director of Clinical Operations and Translational Immunology at The Rockefeller University, shared on LinkedIn: “Excited to share our new

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.